Introduction: Obstructive sleep apnoea (OSA) is highly prevalent and there is considerable
evidence supporting an independent association with a wide range of co-morbidities …

Introduction A high prevalence of OSA has been observed in asthma populations, with
detrimental impact on clinical outcomes. Aim To determine if CPAP treatment of co-existing …

Obstructive sleep apnoea (OSA) is a common disease that can be treated with continuous
positive airway pressure (CPAP). CPAP tolerance may be associated with its compliance …

Nasal continuous positive airway pressure (NCPAP) is a highly effective therapy for
obstructive sleep apnoea (OSA), and can completely abolish apnoeas when effective …

Continuous positive airway pressure (CPAP) remains the best treatment for sleep apnoea
syndrome (SAS). In the 1990s, many authors reported on daily compliance, but all of the …

Purpose Obstructive sleep apnea (OSA) is suggested to predispose to cardiovascular
disease (CVD) events. It is uncertain whether compliance to continuous positive airway …

Background The therapeutic and economic benefits of continuous positive airway pressure
(CPAP) for moderate to severe obstructive sleep apnoea (OSA) syndrome have been …

Objective To assess the predictive factors at 12 month and 10 year adherence to Continuous
Positive Airway Pressure (CPAP) in patients with Obstructive Sleep Apnoea (OSA). Methods …

Background and objective The objective of this study was to evaluate the long‐term
cardiovascular mortality in patients with severe obstructive sleep apnoea (OSA) treated with …

BACKGROUND The sleep apnoea/hypopnoea syndrome (SAHS) is common and treatment
with continuous positive airway pressure (CPAP) is effective. However, not all patients can …